Bentz J, Barney R, Georgantzoglou N, Manxhuka-Kerliu S, Ibishi V, Dacaj-Elshani B
Diseases. 2024; 12(8).
PMID: 39195188
PMC: 11353793.
DOI: 10.3390/diseases12080189.
Castrillo-Diez J, Rivera-Santiago C, Avila-Flores S, Barrera-Barrera S, Barrera-Saldana H
Viruses. 2024; 16(6).
PMID: 38932179
PMC: 11209306.
DOI: 10.3390/v16060887.
Mascarenhas M, Alencoao I, Carinhas M, Martins M, Cardoso P, Mendes F
J Clin Med. 2024; 13(10).
PMID: 38792544
PMC: 11122610.
DOI: 10.3390/jcm13103003.
Gottschlich A, Hong Q, Gondara L, Alam M, Cook D, Martin R
Cancer Epidemiol Biomarkers Prev. 2024; 33(7):904-911.
PMID: 38773687
PMC: 11216858.
DOI: 10.1158/1055-9965.EPI-23-1587.
Munshi R
PLoS One. 2024; 19(1):e0296107.
PMID: 38198475
PMC: 10781159.
DOI: 10.1371/journal.pone.0296107.
Regulatory Effect of Latex on Cell Cycle Progression in Human Papillomavirus-Positive Cervical Cancer Cell Lines: Insights from Gene Expression Analysis.
Cakir M, Bilge U, Ghanbari A, Ashrafi G
Pharmaceuticals (Basel). 2023; 16(12).
PMID: 38139849
PMC: 10747314.
DOI: 10.3390/ph16121723.
Comparing the Costs and Diagnostic Outcomes of Replacing Cytology with the QIAsure DNA Methylation Test as a Triage within HPV Primary Cervical Cancer Screening in The Netherlands.
Puri Sudhir K, Kagenaar E, Meijer M, Hesselink A, Adams E, Turner K
Diagnostics (Basel). 2023; 13(24).
PMID: 38132196
PMC: 10742725.
DOI: 10.3390/diagnostics13243612.
Anti-tumor Effects of Cisplatin Synergist in Combined Treatment with -NT Spores Against Hypoxic Microenvironments in a Mouse Model of Cervical Cancer Caused by TC-1 Cell Line.
Sharafabad B, Abdoli A, Panahi M, Abdolmohammadi Khiav L, Jamur P, Abedi Jafari F
Adv Pharm Bull. 2023; 13(4):817-826.
PMID: 38022809
PMC: 10676560.
DOI: 10.34172/apb.2023.084.
Latex Modulates Immunity-Linked Gene Expression in Human Papillomavirus Positive Cervical Cancer Cell Lines: Evidence from RNA Seq Transcriptome Analysis.
Cakir M, Bilge U, Naughton D, Ashrafi G
Int J Mol Sci. 2023; 24(17).
PMID: 37686451
PMC: 10488141.
DOI: 10.3390/ijms241713646.
Strategies to eliminate cervical cancer in China.
Ji L, Chen M, Yao L
Front Oncol. 2023; 13:1105468.
PMID: 37333817
PMC: 10273099.
DOI: 10.3389/fonc.2023.1105468.
Pilot study of plasma creatine riboside as a potential biomarker for cervical cancer.
Oike T, Osu N, Yoshimoto Y, Obinata H, Yoshikawa K, Harris C
Heliyon. 2023; 9(6):e16684.
PMID: 37292314
PMC: 10245246.
DOI: 10.1016/j.heliyon.2023.e16684.
Two self-sampling strategies for HPV primary cervical cancer screening compared with clinician-collected sampling: an economic evaluation.
Huntington S, Puri Sudhir K, Schneider V, Sargent A, Turner K, Crosbie E
BMJ Open. 2023; 13(6):e068940.
PMID: 37280031
PMC: 10254906.
DOI: 10.1136/bmjopen-2022-068940.
Interventions to increase cervical screening uptake among immigrant women: A systematic review and meta-analysis.
Alam Z, Cairns J, Scott M, Dean J, Janda M
PLoS One. 2023; 18(6):e0281976.
PMID: 37267330
PMC: 10237485.
DOI: 10.1371/journal.pone.0281976.
National cervical cancer burden estimation through systematic review and analysis of publicly available data in Pakistan.
Chughtai N, Perveen K, Gillani S, Abbas A, Chunara R, Manji A
BMC Public Health. 2023; 23(1):834.
PMID: 37147640
PMC: 10163779.
DOI: 10.1186/s12889-023-15531-z.
Raman Spectroscopy for Early Detection of Cervical Cancer, a Global Women's Health Issue-A Review.
Shaikh R, Daniel A, Lyng F
Molecules. 2023; 28(6).
PMID: 36985474
PMC: 10056388.
DOI: 10.3390/molecules28062502.
Genotype heterogeneity of high-risk human papillomavirus infection in Ethiopia.
Seyoum A, Seyoum B, Gure T, Alemu A, Belachew A, Abeje D
Front Microbiol. 2023; 14:1116685.
PMID: 36846744
PMC: 9951590.
DOI: 10.3389/fmicb.2023.1116685.
Using World Cafés to engage an Australian culturally and linguistically diverse community around human papillomavirus vaccination.
Prokopovich K, Phillipson L, West Pitts L, Stanoevska B, Street J, Braunack-Mayer A
Health Expect. 2023; 26(3):1039-1051.
PMID: 36798035
PMC: 10154861.
DOI: 10.1111/hex.13703.
Prevalence of Precancerous Cervical Lesions among Nonvaccinated Kazakhstani Women: The National Tertiary Care Hospital Screening Data (2018).
Imankulova B, Babi A, Issa T, Zhumakanova Z, Knaub L, Yerzhankyzy A
Healthcare (Basel). 2023; 11(2).
PMID: 36673606
PMC: 9859595.
DOI: 10.3390/healthcare11020235.
LncRNA CERS6-AS1, sponging miR-6838-5p, promotes proliferation and invasion in cervical carcinoma cells by upregulating FOXP2.
Yan K, Hu C, Liu C, Chu G, Wang X, Ma S
Histol Histopathol. 2022; 38(7):823-835.
PMID: 36444938
DOI: 10.14670/HH-18-555.
Lycorine upregulates the expression of RMB10, promotes apoptosis and inhibits the proliferation and migration of cervical cancer cells.
Li Z, Zhou Q, Liu X, Li Y, Fan X, Liu G
Int J Mol Med. 2022; 50(6).
PMID: 36367172
PMC: 9662161.
DOI: 10.3892/ijmm.2022.5201.